Brief: Advaxis Announces Listing Transfer To Nasdaq Capital Market
22/12/2020 18:45
Dec 22 (Reuters) - Advaxis Inc ADXS.O :
* ADVAXIS ANNOUNCES LISTING TRANSFER TO NASDAQ CAPITAL MARKET AND ADDITIONAL
180-DAY EXTENSION BY NASDAQ TO REGAIN COMPLIANCE WITH MINIMUM BID PRICE RULE
* ADVAXIS INC - SHARES WILL CONTINUE TO TRADE ON NASDAQ UNDER SYMBOL "ADXS."
Source text for Eikon: ID:nGNX8rNxwB
Further company coverage: ADXS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ayala Pharmaceuticals
See all newsBrief: Ayala Pharmaceuticals Completes Sale Of AL102 To Immunome
Immunome slides on $200 mln equity offering
Immunome edges up after $200 mln equity offering
Brief: Immunome To Acquire AL102 Phase 3 Asset for the Treatment of Desmoid Tumors From Ayala Pharmaceuticals
Brief: Ayala Pharmaceuticals Announces AL102 Receives Orphan Drug Designation for Desmoid Tumors